Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-17

Clinical Trial Update: A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis [Phase 3]

View source ↗

Summary

This update reports on a Phase 3 clinical trial of apremilast in children with mild to moderate plaque psoriasis. The study is currently active and not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OTEZLA (apremilast)

Snippet

Sponsor: Amgen | Conditions: Plaque Psoriasis | Phase 3 | Status: ACTIVE_NOT_RECRUITING